Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japans National Hospital Director Reprimanded For Accepting High Fees For Speeches From Pharma Companies

This article was originally published in PharmAsia News

Executive Summary

Japans National Cardiovascular Center Director Masafumi Kitakaze got his salary reduced for six months for accepting high fees from pharmaceutical companies for speeches. According to the Osaka-based national hospital, Kitakase spoke at 55 events sponsored by pharmac companies from October to December 2006, and received 9.3 million in compensation. The compensation standard, which is 60,000 per hour, is three times higher than the allowed 20,000 or less per hour set by the Ministry of Health, Labor and Welfare. The center also disclosed that Kitakaze falsified the speech time and reported only 7.2 million in compensation.( href='http://www.jiji.com/jc/c?g=soc&k=2009033101128'>Click here for more Japanese language) "National Cardiovascular Center Director Punished For Falsified Report, Receives 9.3 Million In Speech Fees In Three Month" - Jiji Press News (3/31/09)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071511

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel